Eli & Co Lilly, Insider at Coherus BioSciences, Inc. (CHRS), bought 708,064 shares at $13.50 ($2.2M) on 2014-11-12, disclosed to the SEC on 2014-11-12.
Open-market purchase of $2.2M CHRS by Insider. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 543,101 | $0 | 0.0% |
| 2 | $13.50 | 164,963 | $2.2M | 100.0% |
| Total | $3.15 avg | 708,064 | $2.2M | 100% |
| Filing → |
| ZYME | SELL | 2018-09-26 | $33K | — | Filing → |
| ZYME | SELL | 2018-09-20 | $200K | — | Filing → |
| ZYME | SELL | 2018-09-18 | $463K | — | Filing → |